Limited expression of B-cell maturation antigen in acute myeloid leukemia

B-cell maturation antigen (BCMA) was recently identified as a target of T-cell-directed therapy for acute myeloid leukemia (AML), based on the study reporting high BCMA abundance in AML cells using the flow cytometry anti-BCMA antibody clone 19F2 (BCM…

Error: Connection timed out (110)